Literature DB >> 19779720

The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.

Britta Engelhardt1, Lydia Sorokin.   

Abstract

The central nervous system (CNS) is tightly sealed from the changeable milieu of blood by the blood-brain barrier (BBB) and the blood-cerebrospinal fluid (CSF) barrier (BCSFB). While the BBB is considered to be localized at the level of the endothelial cells within CNS microvessels, the BCSFB is established by choroid plexus epithelial cells. The BBB inhibits the free paracellular diffusion of water-soluble molecules by an elaborate network of complex tight junctions (TJs) that interconnects the endothelial cells. Combined with the absence of fenestrae and an extremely low pinocytotic activity, which inhibit transcellular passage of molecules across the barrier, these morphological peculiarities establish the physical permeability barrier of the BBB. In addition, a functional BBB is manifested by a number of permanently active transport mechanisms, specifically expressed by brain capillary endothelial cells that ensure the transport of nutrients into the CNS and exclusion of blood-borne molecules that could be detrimental to the milieu required for neural transmission. Finally, while the endothelial cells constitute the physical and metabolic barrier per se, interactions with adjacent cellular and acellular layers are prerequisites for barrier function. The fully differentiated BBB consists of a complex system comprising the highly specialized endothelial cells and their underlying basement membrane in which a large number of pericytes are embedded, perivascular antigen-presenting cells, and an ensheathment of astrocytic endfeet and associated parenchymal basement membrane. Endothelial cell morphology, biochemistry, and function thus make these brain microvascular endothelial cells unique and distinguishable from all other endothelial cells in the body. Similar to the endothelial barrier, the morphological correlate of the BCSFB is found at the level of unique apical tight junctions between the choroid plexus epithelial cells inhibiting paracellular diffusion of water-soluble molecules across this barrier. Besides its barrier function, choroid plexus epithelial cells have a secretory function and produce the CSF. The barrier and secretory function of the choroid plexus epithelial cells are maintained by the expression of numerous transport systems allowing the directed transport of ions and nutrients into the CSF and the removal of toxic agents out of the CSF. In the event of CNS pathology, barrier characteristics of the blood-CNS barriers are altered, leading to edema formation and recruitment of inflammatory cells into the CNS. In this review we will describe current knowledge on the cellular and molecular basis of the functional and dysfunctional blood-CNS barriers with focus on CNS autoimmune inflammation.

Entities:  

Mesh:

Year:  2009        PMID: 19779720     DOI: 10.1007/s00281-009-0177-0

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  116 in total

Review 1.  Endothelial-pericyte interactions in angiogenesis.

Authors:  Holger Gerhardt; Christer Betsholtz
Journal:  Cell Tissue Res       Date:  2003-07-22       Impact factor: 5.249

Review 2.  Origin, nature, and some functional considerations of intraventricular macrophages, with special reference to the epiplexus cells.

Authors:  E A Ling; C Kaur; J Lu
Journal:  Microsc Res Tech       Date:  1998-04-01       Impact factor: 2.769

3.  PSGL-1 is not required for development of experimental autoimmune encephalomyelitis.

Authors:  Inga Osmers; Daniel C Bullard; Scott R Barnum
Journal:  J Neuroimmunol       Date:  2005-09       Impact factor: 3.478

4.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

Review 5.  Involvement of the choroid plexus in central nervous system inflammation.

Authors:  B Engelhardt; K Wolburg-Buchholz; H Wolburg
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

6.  Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.

Authors:  Douglas B Gould; F Campbell Phalan; Guido J Breedveld; Saskia E van Mil; Richard S Smith; John C Schimenti; Umberto Aguglia; Marjo S van der Knaap; Peter Heutink; Simon W M John
Journal:  Science       Date:  2005-05-20       Impact factor: 47.728

7.  Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway.

Authors:  P Adamson; S Etienne; P O Couraud; V Calder; J Greenwood
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

8.  Distribution of dystroglycan in normal adult mouse tissues.

Authors:  M Durbeej; M D Henry; M Ferletta; K P Campbell; P Ekblom
Journal:  J Histochem Cytochem       Date:  1998-04       Impact factor: 2.479

9.  Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin.

Authors:  Richard Milner
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

10.  L-Selectin-deficient SJL and C57BL/6 mice are not resistant to experimental autoimmune encephalomyelitis.

Authors:  Chiara Uboldi; Axinia Döring; Carsten Alt; Pila Estess; Mark Siegelman; Britta Engelhardt
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

View more
  248 in total

Review 1.  The immunology of acute stroke.

Authors:  Ángel Chamorro; Andreas Meisel; Anna M Planas; Xabier Urra; Diederik van de Beek; Roland Veltkamp
Journal:  Nat Rev Neurol       Date:  2012-06-05       Impact factor: 42.937

2.  Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium.

Authors:  Robert R Rigor; Richard S Beard; Olesya P Litovka; Sarah Y Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-07       Impact factor: 4.249

Review 3.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 4.  Neurovascular unit: a focus on pericytes.

Authors:  Inês Sá-Pereira; Dora Brites; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

Review 5.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

Review 6.  Strategies to target drugs to gliomas and CNS metastases of solid tumors.

Authors:  B Milojkovic Kerklaan; O van Tellingen; A D R Huitema; J H Beijnen; W Boogerd; J H M Schellens; D Brandsma
Journal:  J Neurol       Date:  2015-10-17       Impact factor: 4.849

Review 7.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

8.  Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep.

Authors:  Aparna Patra; Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Yow-Pin Lim; James F Padbury; William A Banks; Barbara S Stonestreet
Journal:  Neuroscience       Date:  2017-01-09       Impact factor: 3.590

9.  Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Craig Steward; Flora Rueckert; Matt Widdison; Robert Coffman; Atiyeh Afjei; Stephen C Noctor; Randi Hagerman; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Brain Res       Date:  2014-12-09       Impact factor: 3.252

Review 10.  TREK-king the blood-brain-barrier.

Authors:  Stefan Bittner; Tobias Ruck; Juncal Fernández-Orth; Sven G Meuth
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.